Summary
The kinetic disposition of yohimbine was examined in eight young male subjects following a single oral dose of 10 mg yohimbine hydrochloride. The drug was rapidly absorbed (absorption half-time 0.17±0.11 h) and rapidly eliminated from the plasma (elimination half-life 0.60±0.26 h).
This clearance of yohimbine from plasma was constant over approximately 10 elimination half-lives, suggesting that distribution into a second pharmacokinetically distinct compartment was not responsible for the rapid decline in plasma yohimbine levels.
Urinary excretion and the partitioning of the drug into red blood cells (RBC) was investigated. In the 24 h following oral administration of the drug, virtually no yohimbine was eliminated in the urine (0.35±0.50% of the administered dose). Furthermore, only 20% of blood-borne yohimbine was located in RBC.
These results suggest that yohimbine is eliminated primarily through metabolism since the rapid plasma clearance of yohimbine was not the result of renal elimination or sequestration by RBC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Holmberg G, Gershon S, Beck LH (1962) Yohimbine as an autonomic test drug. Nature 193: 1313–1314
Morales A, Surridge DHC, Marshall PG, Fenemore J (1982) Nonhormonal pharmacological treatment of organic impotence. J Urol 128: 45–47
Cooper AJ (1972) Diagnosis and management of “Endocrine Impotence”. Br Med J 2: 34–36
Wabrek AJ (1979) Sexual dysfunction associated with diabetes mellitus. J Fam Pract 8: 735–740
Morales A, Condra M, Owen JA, Surridge DHC, Fenemore J, Harris C (1987) The effectiveness of Yohimbine in the treatment of organic impotence: A controlled trial. J Urol (in press)
Holmberg G, Gershon S (1961) Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia 2: 93–106
Charney DS, Heninger GR, Sternberg DE (1982) Assessment of α-adrenergic autoreceptor function in humans: Effects of oral yohimbine. Life Sci 30: 2033–2041
Henaur SA, Gillespie HK, Hollister LE (1984) Yohimbine and the model anxiety state. J Clin Psychiatr 45: 512–515
Uhde TW, Boulenger JP, Post RM, Siever LJ, Vittone BJ, Jimerson DC, Roy-Byrne PP (1984) Fear and anxiety: Relationship to noradrenergic function. Psychopathology 17 [Suppl 3]: 8–23
Goldberg MR, Speier L, Robertson D (1984) Assay of yohimbine in human plasma using high performance liquid chromatography with electrochemical detection. J Liquid Chromatogr 7: 1003–1012
Owen JA, Nakatsu SL, Condra M, Surridge DH, Fenemore J, Morales A (1985) Sub-nanogram analysis of yohimbine and related compounds by high-performance liquid chromatography. J Chromatogr 342: 333–340
Majors RE (1972) High performance liquid chromatography on small particle silica gel. Anal Chem 44: 1722–1726
Brown RD, Manno JE (1978) ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691
Altman PL, Dittmer DS (1971) Respiration and circulation. American Societies for Experimental Biology, Bethesda, MD, p 428
Aas K, Blegen E (1949) The renal blood flow and the glomerular filtration rate in congestive heart failure and some other clinical conditions. Scand J Clin Lab Invest 1: 22–32
Gibaldi M, Perrier D (1975) Pharmacokinetics. Marcel Dekker, New York, pp 33–40
Ho AKJ, Hoffman DB, Gershon S, Loh HH (1971) Distribution and metabolism of tritiated yohimbine in mice. Arch Int Pharmacodyn 194: 304–315
Maass AR, Jenkins B, Shenn Y, Tannenbaum P (1969) Studies on absorption, excretion and metabolism of3H-reserpine in man. Clin Pharmacol Ther 10: 366–371
Marzo A, Chirardi P, Parenti MA, Merlo L, Marchetti G, Cavalca L, Omboni E, Pignataro T, Ligresti A (1981) The pharmacokinetics of a combination of raubascine, dihydroergocriptine and dihydroergotamine in dogs and human beings. Int Farmaco 36: 173–197
Stitzel RE (1977) The biological fate of reserpine. Pharmacol Rev 28: 179–205
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Owen, J.A., Nakatsu, S.L., Fenemore, J. et al. The pharmacokinetics of yohimbine in man. Eur J Clin Pharmacol 32, 577–582 (1987). https://doi.org/10.1007/BF02455991
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02455991